|
1
|
DeSantis C, Ma JM, Bryan L and Jemal A:
Breast Cancer Statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Polakis P: The oncogenic activation of
beta-catenin. Curr Opin Genet Dev. 9:15–21. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Howe LR and Brown AM: Wnt signaling and
breast cancer. Cancer Biol Ther. 3:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Incassati A, Chandramouli A, Eelkema R and
Cowin P: Key signaling nodes in mammary gland development and
cancer: β-catenin. Breast Cancer Res. 12:122010
|
|
5
|
Lin SY, Xia WY, Wang JC, Kwong KY, Spohn
B, Wen Y, Pestell RG and Hung MC: beta-catenin, a novel prognostic
marker for breast cancer: Its roles in cyclin D1 expression and
cancer progression. Proc Natl Acad Sci USA. 97:4262–4266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Behrens J: Control of beta-catenin
signaling in tumor development. Ann Ny Acad Sci. 910:21–35. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turashvili G, Bouchal J, Burkadze G and
Kolar Z: Wnt signaling pathway in mammary gland development and
carcinogenesis. Pathobiology. 73:213–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Verras M and Sun ZJ: Roles and regulation
of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett.
237:22–32. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amado NG, Fonseca BF, Cerqueira DM, Neto
VM and Abreu JG: Flavonoids: Potential Wnt/beta-catenin signaling
modulators in cancer. Life Sci. 89:545–554. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamamoto H, Tsukahara K, Kanaoka Y, Jinno
S and Okayama H: Isolation of a mammalian homologue of a fission
yeast differentiation regulator. Mol Cell Biol. 19:3829–3841. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spellman R, Llorian M and Smith CW:
Crossregulation and functional redundancy between the splicing
regulator PTB and its paralogs nPTB and ROD1. Mol Cell. 27:420–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maniatis T and Tasic B: Alternative
pre-mRNA splicing and proteome expansion in metazoans. Nature.
418:236–243. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hagen RM and Ladomery MR: Role of splice
variants in the metastatic progression of prostate cancer. Biochem
Soc Trans. 40:870–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brazao TF, Demmers J, van IJcken W,
Strouboulis J, Fornerod M, Romão L and Grosveld FG: A new function
of ROD1 in nonsense-mediated mRNA decay. FEBS Lett. 586:1101–1110.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen B, Zhao AG, Shao J, Mu XY, Jiang L
and Liu JW: The effects of PTBP3 silencing on the proliferation and
differentiation of MKN45 human gastric cancer cells. Life Sci.
114:29–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo J, Deng ZL, Luo X, Tang N, Song WX,
Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol
for rapid generation of recombinant adenoviruses using the Ad Easy
system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lv K, Guo YJ, Zhang YL, Wang K, Li K, Zhu
Y and Sun S: Transient inhibition of foot-and-mouth disease virus
replication by siRNAs silencing VP1 protein coding region. Res Vet
Sci. 86:443–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anderson RD, Haskell RE, Xia H, Roessler
BJ and Davidson BL: A simple method for the rapid generation of
recombinant adenovirus vectors. Gene Ther. 7:1034–1038. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu FI, Sun YH, Wei CY, Thisse C and Thisse
B: Tissue-specific derepression of TCF/LEF controls the activity of
the Wnt/β-catenin pathway. Nat Commun. 5:53682014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gaspar C and Fodde R: APC dosage effects
in tumorigenesis and stem cell differentiation. Int J Dev Biol.
48:377–386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen GP, Shukeir N, Potti A, Sircar K,
Aprikian A, Goltzman D and Rabbani SA: Up-regulation of Wnt-1 and
β-catenin production in patients with advanced metastatic prostate
carcinoma-Potential pathogenetic and prognostic implications.
Cancer. 101:1345–1356. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang F, Zeng Q, Yu G, Li S and Wang CY:
Wnt/beta-catenin signaling inhibits death receptor-mediated
apoptosis and promotes invasive growth of HNSCC. Cell Signal.
18:679–687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fiebig HH, Berger DP, Winterhalter BR and
Plowman J: In vitro and In vivo evaluation of Us-Nci compounds in
human tumor xenografts. Cancer Treat Rev. 17:109–117. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang D, Fei F, Li S, Zhao Y, Yang Z, Qu
J, Zhang X, Yin Y and Zhang S: The role of β-catenin in the
initiation and metastasis of TA2 mice spontaneous breast cancer. J
Cancer. 8:2114–2123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun B, Zhang S, Zhang D, Liu Y, Li Y, Rong
Z, Zhu Y and Jia X: Clusterin is associated with spontaneous breast
cancer in TA2 mice. FEBS Lett. 581:3277–3282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lindvall C, Evans NC, Zylstra CR, Li Y,
Alexander CM and Williams BO: The Wnt signaling receptor Lrp5 is
required for mammary ductal stem cell activity and Wnt1-induced
tumorigenesis. J Biol Chem. 281:35081–35087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rosano L, Cianfrocca R, Spinella F, Di
Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG and Bagnato
A: Acquisition of chemoresistance and EMT phenotype is linked with
activation of the endothelin A receptor pathway in ovarian
carcinoma cells. Clin Cancer Res. 17:2350–2360. 2011. View Article : Google Scholar : PubMed/NCBI
|
